<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04681014</url>
  </required_header>
  <id_info>
    <org_study_id>CTEPH-SOLUTION</org_study_id>
    <nct_id>NCT04681014</nct_id>
  </id_info>
  <brief_title>CTEPH in Patients With Prior Pulmonary Embolism and Risk Score Validation</brief_title>
  <acronym>CTEPH-SOLUTION</acronym>
  <official_title>Evidence-based Detection of CTEPH in Patients With Prior Pulmonary Embolism: Risk Score Evaluation and Validation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>iPHNET (italian Pulmonary Hypertension NETwork)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>iPHNET (italian Pulmonary Hypertension NETwork)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      CTEPH-SOLUTION aims to create a risk score for the early detection of Chronic Thrombo-Embolic&#xD;
      Pulmonary Hypertension (CTEPH) among patients with previous pulmonary embolism.&#xD;
&#xD;
      The risk score, created on retrospective data, will be validated on newly diagnosed pulmonary&#xD;
      embolism patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      CTEPH-SOLUTION is a multicenter observational cross-sectional and prospective study in&#xD;
      patients with a prior and new diagnosis of pulmonary embolism.&#xD;
&#xD;
      Patients with prior pulmonary embolism will be screened at baseline with doppler&#xD;
      echocardiography: an estimated sPAP ≥ 40 mmHg will be the indication for pulmonary&#xD;
      hypertension detection. After 24 months from baseline, patients will be followed-up for CTEPH&#xD;
      detection. CTEPH diagnosis will be carried out according to the current ESC/ERS guidelines.&#xD;
&#xD;
      Incident (pulmonary embolism episode at least three months before the baseline) and prevalent&#xD;
      (pulmonary embolism episode) patients will be enrolled.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 21, 2016</start_date>
  <completion_date type="Anticipated">July 31, 2022</completion_date>
  <primary_completion_date type="Actual">July 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>CTEPH-SOLUTION score</measure>
    <time_frame>24 months</time_frame>
    <description>The CTEPH-SOLUTION score will be created on retrospective parameters (i.e., demographic data, diagnostic and clinical information, risk factors, laboratories parameters) collected on pulmonary embolism patients.&#xD;
The minimum and maximum values will be defined after the multivariate statistical analysis, and the risk factors analyzed a posteriori. Higher scores mean a worse outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The number of the subject with a diagnosis of CTEPH on the total number of subjects enrolled.</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">1218</enrollment>
  <condition>Chronic Thromboembolic Pulmonary Hypertension</condition>
  <condition>Pulmonary Embolism</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with prior pulmonary embolism followed by centres for anticoagulant therapy&#xD;
        management (TAO centres) will be enrolled by the investigator's centres and undergo&#xD;
        baseline evaluation for prevalent CTEPH detection; al CTEPH will be confirmed by right&#xD;
        heart catheterization.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 at baseline evaluation&#xD;
&#xD;
          -  Diagnosis of prior (&gt; 30 days from pulmonary embolism onset) or new-onset pulmonary&#xD;
             embolism, according to the ESC guidelines on the diagnosis and management of acute&#xD;
             pulmonary embolism&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients without pulmonary embolism diagnosis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences. AOU Policlinico Umberto I</name>
      <address>
        <city>Rome</city>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 17, 2020</study_first_submitted>
  <study_first_submitted_qc>December 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 23, 2020</study_first_posted>
  <last_update_submitted>December 22, 2020</last_update_submitted>
  <last_update_submitted_qc>December 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

